Nogapendekin alfa inbakicept, CAS 1850381-92-8

Product Description: Nogapendekin alfa inbakicept is a IL-15 superagonist that enhances anti-tumor immune responses by activating NK cells and T cells, and is being studied for the treatment of non-muscle-invasive bladder cancer (NMIBC)[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Chamie K, et al. IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer. NEJM Evid. 2023 Jan;2(1):EVIDoa2200167.

CAS Number: 1850381-92-8

Molecular Weight: N/A

Compound Purity: 99.50

Research Area: Inflammation/Immunology;Cancer

Target: Interleukin Related

• Artikelnummer: MEXHY-P991077-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P991077-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated